Newsletter | March 15, 2023

03.15.23 -- 4 Lessons Learned Developing Cancer Immunotherapies
 
From The Editor
CPHI Report Presents Shifting Outsourcing Realities
 
By Louis Garguilo, chief editor, Outsourced Pharma

While positive in tone, the 6th annual CPHI report demonstrates our outsourcing sands are indeed shifting. Which way for sponsors, CDMOs, and individual countries? Here's an analysis from our chief editor.
Featured Editorial
4 Lessons Learned Developing Cancer Immunotherapy Treatments
 
By Frank Bedu-Addo, Ph.D., and Gregory Conn, Ph.D., PDS Biotech

The ability to build up cancer-attacking T cells in cancer patients remains a major limitation of current immunotherapy approaches. PDS Biotech's CEO and CSO share four lessons they have learned along the way in developing their lead product, PDS0101, an immunotherapy targeting HPV-positive cancers.
Industry Insights
Optimizing AAV Manufacture Purification
Article | By Orjana Terova and Zoltan Gulyas, Thermo Fisher Scientific

Adeno-associated viruses are becoming the vector of choice for delivering therapeutic genes. Learn more about technology being explored to unlock their full potential.
The Digitalization Of Biopharma Process Development, Manufacturing
White Paper | By Wolfram Schulze, Rentschler Biopharma

The fourth industrial revolution is coming. Explore the three essentials of bioprocess development and manufacturing digitalization: digital literacy, digital trust, and prioritization.
Drug Discovery And Screening, A Digital Era For RNA-LNP Therapeutics
Article | Precision NanoSystems

Learn about the key stages of drug discovery and screening, along with how to overcome key bottlenecks in screening mRNA-LNPs, to rapidly develop genomic medicines.
CDMO Timebombs: Five Ways The Wrong Partner Can Lead To Trouble
Article | Thermo Fisher Scientific

A manufacturing partner that can't manage the complexities of your biologic can cause problems large and small, putting your next level of funding, or even the future of your company, in jeopardy.
Quality By Design: The Highest-Standard Approach To Process Validation
Case Study | AGC Biologics

The challenge was to develop and validate manufacturing processes for two novel molecules, one in Phase 1 development and the other in Phase 3.
3 Important Developments In Aseptic Connection Technology
Webinar | CPC

Learn about the latest aseptic connectors to help optimize today’s processes and get a sneak peek into the future of single-use technology.
Solutions
Cell And Gene Capacity Update
Andelyn Biosciences
Accelerating Your Product Through Development To Commercialization
PCI Pharma Services
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.